BOULDER, Colo., Feb. 8, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual Global Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
|
Event: |
Leerink Partners Annual Global Healthcare Conference |
|
Presenter: |
Ron Squarer, Chief Executive Officer |
|
Date: |
Wednesday, February 15, 2017 |
|
Time: |
3:00 p.m. Eastern Time |
|
Webcast: |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).
|
CONTACT: |
Tricia Haugeto |
|
Array BioPharma Inc. | |
|
303-386-1193 | |
SOURCE Array BioPharma Inc.
